Sprout Health Review: It Gets the Boring Things Right — Cold Chain, Cancellation and a Straight Disclaimer

What Is Sprout Health?

Sprout Health is a cash-pay telehealth platform operating as Sprout Health Partners LLC from Encinitas, California. It connects patients with independent licensed clinicians through the MD Integrations provider network and fulfils prescriptions through US-based 503A compounding pharmacies. It says it is LegitScript certified.

The catalogue covers both sides of the market. Compounded semaglutide starts at $149/month and compounded tirzepatide at $199/month, with pricing flat regardless of dose — so titrating up does not raise your bill. Brand-name options are also available at cash prices, with Wegovy from $1,579 and Zepbound from $1,249. A $99 first-month offer appears on some landing pages.

Where Sprout distinguishes itself is in the operational details that most of this market handles badly. It states shipping is 'discreet, refrigerated' from a US pharmacy — for a temperature-sensitive peptide that is the correct standard and one many competitors do not mention at all. Cancellation is self-service through a subscriptions tab in your account rather than an email you have to chase. If a clinician determines treatment is not clinically appropriate, the order is automatically cancelled and you receive a full refund. And a monthly check-in is required before each refill.

Its FDA disclosure is equally direct: 'Compounded GLP-1 and GIP/GLP-1 are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA.' That is complete and unhedged, and better than most competitors manage.

Medications Offered & Pricing

Prices are as published on 6 August 2026, and this is the one area where Sprout is genuinely confusing. Different landing pages carry different figures: its main funnel shows compounded semaglutide from $149/month and a $99 first month, while independent coverage from the same period reports $199 for a first month rising to $249/month, a three-month supply normally $615 discounted to $315, and at least one customer describing a flat $299/month. Those cannot all describe the same plan. Screenshot the price and terms you are quoted at checkout, and check your second statement against it. The brand-name cash prices are real but very high — if you have any insurance coverage for Wegovy or Zepbound, pursue it through your own plan before paying $1,249 or more here.

Brand-Name or Compounded?

Sprout sells both compounded and brand-name products, which gives a genuine choice about regulatory risk. Wegovy and Zepbound are FDA-approved medicines; the compounded semaglutide and tirzepatide are not.

Sprout's own disclosure of that distinction is one of the better ones we have read: compounded GLP-1 and GIP/GLP-1 products 'are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA'. It names all three dimensions — safety, effectiveness and quality — rather than the vaguer wording most competitors use, and it makes no 'same active ingredient as Wegovy' style claim, which is the construction that drew an FDA warning letter to a competitor in February 2026.

The compounding is done by 503A pharmacies. Section 503A pharmacies compound for individually identified patients under state pharmacy board oversight and are not held to the federal current good manufacturing practice standards that govern 503B outsourcing facilities. For a sterile weekly injectable that is a real difference in manufacturing assurance, and it applies to Sprout as it does to most of this market.

Prescribing runs through MD Integrations, an established third-party telehealth clinician network. Naming the provider network is more transparency than most competitors offer, even though individual prescribers are not identified.

The Consultation Process

Eligibility

• •Eligibility is determined by a licensed clinician reviewing your pre-qualification quiz. No lab work and no video appointment are required.
• •States served are not published on the pages we reviewed. Confirm availability before subscribing.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst in the days after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Because no baseline bloodwork is taken, nothing is screened for before you start — no HbA1c, no thyroid or renal function, no liver panel. If you have any relevant history, raise it explicitly in the questionnaire rather than assuming it will be picked up.
• •Anyone who wants a medication whose safety and efficacy have been established in trials should choose the brand-name Wegovy or Zepbound option here rather than the compounded one, cost permitting.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Discreet and refrigerated from a US pharmacy, which is the correct handling for a temperature-sensitive peptide and something a surprising number of competitors do not state at all. It is a meaningful point in Sprout's favour — several providers we have reviewed this month have complaints about medication arriving warm. Still inspect deliveries on arrival and photograph anything that arrives with failed cold packs.

• •Flat pricing that does not increase as your dose rises
• •Both compounded and brand-name Wegovy and Zepbound available
• •Explicitly refrigerated shipping from a US pharmacy
• •Self-service cancellation from a subscriptions tab in your account
• •Full refund if a clinician determines treatment is not appropriate
• •Monthly check-in required before each refill
• •Clinician messaging through your account
• •HIPAA-compliant record handling
• •Named legal entity and named provider network (MD Integrations)
• •Clear, complete FDA disclosure naming safety, effectiveness and quality

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Sprout Health May Be Best For

• •People who want compounded GLP-1 treatment but are wary of providers that make cancelling difficult
• •Anyone who has been burned by medication arriving warm and wants a provider that states cold-chain handling
• •Patients who will titrate to a high maintenance dose and want the price fixed from the start
• •People who may want to move from compounded to brand-name Wegovy or Zepbound without changing provider
• •Buyers who value clear regulatory disclosure over the absolute lowest headline price

Limitations

• •No labs and no video visit is the real clinical weakness. Sprout requires a monthly check-in before refills, which is better than autopilot shipping, but nothing is measured before you start a medication that affects glucose regulation, gallbladder function and kidney hydration status. Providers like Hone Health run a 50-biomarker panel first and DudeMeds bundles bloodwork into a $77 plan; against those, a questionnaire is thin.
• •The pricing inconsistency is the most frustrating thing about evaluating this service. Across its own landing pages and independent coverage from the same fortnight we found $149, $199, $249, $299 and a discounted $315 three-month figure. Some of that is promotional variation and some is different products, but the effect is that no one can tell you what you will actually pay. Screenshot your quote, and verify month two.
• •The brand-name pricing needs a health warning of its own. $1,579 for Wegovy and $1,249 for Zepbound are unadjusted cash prices, and paying them without first exhausting insurance, manufacturer savings programmes and your own pharmacy's pricing would be a costly mistake. Sprout offers no insurance navigation, so that work is entirely yours.
• •503A compounding remains the underlying limitation, as it is across most of this market. It is not a criticism unique to Sprout, but for a sterile injectable taken weekly for months, the difference between state-board oversight and federal cGMP is real, and the pharmacy is unnamed so you cannot check it yourself.
• •In fairness, this provider does several things we have spent the past month criticising others for failing to do. It lets you cancel yourself. It refunds you if it will not treat you. It refrigerates the shipment. It discloses its regulatory position completely and without spin. Those are unglamorous operational choices that reflect an organisation designed around the customer rather than around retention, and they are the reason this rates above cheaper competitors.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Sprout Health is a reminder that the things separating good telehealth providers from bad ones are mostly unglamorous. It ships refrigerated. It lets you cancel from a button in your own account instead of an email nobody answers. It refunds you in full if a clinician decides not to treat you. It requires a check-in before each refill rather than shipping on autopilot. And it describes its own regulatory position completely and without spin — naming safety, effectiveness and quality — while avoiding the equivalence claims that got a competitor an FDA warning letter this year.

After a month of reviewing providers whose most common complaint is that customers could not stop being billed, or that medication arrived warm, or never arrived at all, those choices count for a lot. Add flat pricing that does not climb as you titrate, both compounded and brand-name options, and a named legal entity and provider network, and the operational picture is genuinely good.

Two things hold it back. Clinically it is thin: no bloodwork and no video consultation means nothing is measured before you start, which is the standard weakness of questionnaire-based prescribing and one that better providers have moved past. And commercially it is confusing: we found $149, $199, $249, $299 and $315 quoted across its own pages and independent listings within the same fortnight, which makes it impossible to tell a reader what they will actually pay.

We rate Sprout Health 3.5 out of 5. If you have decided on compounded GLP-1 treatment and want a provider that will let you leave when you want and will ship the medication properly, this is one of the more trustworthy operators we have reviewed. Screenshot your quoted price, verify month two, and if you can afford brand-name treatment, pursue insurance coverage elsewhere before paying $1,249 cash here.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, effectiveness or quality. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.